The reduced expression of EphB1 has been linked with invasion and metastasis in both colorectal [21] and gastric carcinomas [22], while blocking EphB1 forward signalling may have a clinical benefit in relieving bone cancer pain [23]. This evidence concerns the gene EPHB1 and gastric carcinoma.